vTv Therapeutics KOL breakfast Nov 2017

New York, November 16, 2017

Please join vTv Therapeutics for a KOL breakfast highlighting the Alzheimer's drug discovery landscape and novel mechanisms of action.

Presentations start at 8:30 am EST (registration/breakfast at 8:00 am EDT)


For more information please contact Mike Biega (mbiega@troutgroup.com)

Register for Event / Log Back in

Additional menu options can be found in the menu bar on the left or at the top.

vTv Therapeutics, Inc. [VTVT] US$63 MM MCap
Da­ta-in hand from two Ph. 2 Di­a­betes (T2) trials: 1. Glu­cok­i­nase Ac­ti­va­tor (TT­P399); 2. Oral GLP-1r (TT­P273). Eval­u­at­ing TT­P399 as an add-on ther­a­py to in­sulin ther­a­py in a 12 week phase 1/2 trial in... [more in­for­ma­tion]

Event Contact

Mike Biega
Solebury Trout